Cécile Tremblay
Cécile Tremblay
Affiliation inconnue
Adresse e-mail validée de umontreal.ca
Citée par
Citée par
On-demand preexposure prophylaxis in men at high risk for HIV-1 infection
JM Molina, C Capitant, B Spire, G Pialoux, L Cotte, I Charreau, ...
N Engl J Med 373, 2237-2246, 2015
High rates of forward transmission events after acute/early HIV-1 infection
BG Brenner, M Roger, JP Routy, D Moisi, M Ntemgwa, C Matte, JG Baril, ...
The Journal of infectious diseases 195 (7), 951-959, 2007
Evolution and transmission of stable CTL escape mutations in HIV infection
PJR Goulder, C Brander, Y Tang, C Tremblay, RA Colbert, MM Addo, ...
Nature 412 (6844), 334-338, 2001
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1
JM Strizki, C Tremblay, S Xu, L Wojcik, N Wagner, W Gonsiorek, ...
Antimicrobial agents and chemotherapy 49 (12), 4911-4919, 2005
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study
JM Molina, I Charreau, B Spire, L Cotte, J Chas, C Capitant, C Tremblay, ...
The lancet HIV 4 (9), e402-e410, 2017
Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: a cohort and nested case–control study using Quebec's public health …
M Durand, O Sheehy, JG Baril, J Lelorier, CL Tremblay
JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (3), 245-253, 2011
Wide variation in the multiplicity of HIV-1 infection among injection drug users
KJ Bar, H Li, A Chamberland, C Tremblay, JP Routy, T Grayson, C Sun, ...
Journal of virology 84 (12), 6241-6247, 2010
On demand PrEP with oral TDF-FTC in MSM: results of the ANRS Ipergay trial
JM Molina, C Capitant, B Spire, G Pialoux, C Chidiac, I Charreau, ...
Conference on retroviruses and opportunistic infections 2015, 2015
Hepatitis C virus genotype 7, a new genotype originating from central Africa
DG Murphy, E Sablon, J Chamberland, E Fournier, R Dandavino, ...
Journal of clinical microbiology 53 (3), 967-972, 2015
Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study
A Iannello, MR Boulassel, S Samarani, O Debbeche, C Tremblay, E Toma, ...
The Journal of immunology 184 (1), 114-126, 2010
The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals
M Veillette, M Coutu, J Richard, LA Batraville, O Dagher, N Bernard, ...
Journal of virology 89 (1), 545-551, 2015
Strong in vitro synergy between the fusion inhibitor T-20 and the CXCR4 blocker AMD-3100.
CL Tremblay, C Kollmann, F Giguel, TC Chou, MS Hirsch
Journal of acquired immune deficiency syndromes (1999) 25 (2), 99-102, 2000
CD160 and PD-1 co-expression on HIV-specific CD8 T cells defines a subset with advanced dysfunction
Y Peretz, Z He, Y Shi, B Yassine-Diab, JP Goulet, R Bordi, ...
Public Library of Science 8 (8), e1002840, 2012
Anti-human immunodeficiency virus interactions of SCH-C (SCH 351125), a CCR5 antagonist, with other antiretroviral agents in vitro
CL Tremblay, F Giguel, C Kollmann, Y Guan, TC Chou, BM Baroudy, ...
Antimicrobial agents and chemotherapy 46 (5), 1336-1339, 2002
Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults
K Weiss, DE Low, L Cortes, A Beaupre, R Gauthier, P Gregoire, M Legare, ...
Canadian respiratory journal 11 (8), 589-593, 2004
Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review
F Lamothe, P D'Amico, P Ghosn, C Tremblay, J Braidy, JV Patenaude
Clinical infectious diseases 21 (6), 1469-1470, 1995
Canadian guideline on HIV pre-exposure prophylaxis and nonoccupational postexposure prophylaxis
DHS Tan, MW Hull, D Yoong, C Tremblay, P O’byrne, R Thomas, J Kille, ...
CMAJ 189 (47), E1448-E1458, 2017
Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV‐1 reservoirs: results from a multicentre randomized clinical study
JP Routy, CL Tremblay, JB Angel, B Trottier, D Rouleau, JG Baril, ...
HIV medicine 13 (5), 291-296, 2012
A side by side comparison of Bruker Biotyper and VITEK MS: utility of MALDI-TOF MS technology for microorganism identification in a public health reference laboratory
S Lévesque, PJ Dufresne, H Soualhine, MC Domingo, S Bekal, ...
PloS one 10 (12), e0144878, 2015
Loss of memory B cells during chronic HIV infection is driven by Foxo3a-and TRAIL-mediated apoptosis
J Van Grevenynghe, RA Cubas, A Noto, S DaFonseca, Z He, Y Peretz, ...
The Journal of clinical investigation 121 (10), 3877-3888, 2011
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20